Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6,900%. A quarter ago, it was expected that this drug developer would post a loss of $0.37 per share when it actually produced a loss of $0.06, delivering a surprise of 83.78%.Over the last four quarters, the com ...